A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ) ; volume:13 ; number:1 ; day:22 ; month:9 ; year:2014 ; pages:1 ; date:9.2014
Malaria journal ; 13, Heft 1 (22.9.2014), 1, 9.2014
- Creator
-
Stein, Daniel S.
- Contributor
-
Jain, Jay Prakash
Lickliter, Jason
Kangas, Michael
Machineni, Surendra
Griffin, Paul
Lefèvre, Gilbert
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-13-S1-P85
- URN
-
urn:nbn:de:1111-2016080649691
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stein, Daniel S.
- Jain, Jay Prakash
- Lickliter, Jason
- Kangas, Michael
- Machineni, Surendra
- Griffin, Paul
- Lefèvre, Gilbert
- SpringerLink (Online service)
Other Objects (12)
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Towards optimal design of anti-malarial pharmacokinetic studies
Pharmacokinetic analysis of new synthetic antimalarial N-251
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Towards optimal design of anti-malarial pharmacokinetic studies
Pharmacokinetic analysis of new synthetic antimalarial N-251
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
Pharmacokinetic-pharmacodynamic modeling of antibacterial agents in tissues and body fluids
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Towards optimal design of anti-malarial pharmacokinetic studies